Asia-Pacific Health 2020 and Genomics without Borders: Co-Production of Knowledge by Science and Society Partnership for Global Personalized Medicine.
作者信息
Ozdemir Vural, Muljono David H, Pang Tikki, Ferguson Lynnette R, Manamperi Aresha, Samper Sofia, Someya Toshiyuki, Tassé Anne Marie, Tsai Shih-Jen, Zhou Hong-Hao, Lee Edmund J D
机构信息
Centre of Genomics and Policy, Department of Human Genetics, Faculty of Medicine, McGill University, Montreal, QC, Canada.
出版信息
Curr Pharmacogenomics Person Med. 2011 Mar 1;9(1):1-5. doi: 10.2174/187569211794728841.
Abstract
摘要
相似文献
1
Asia-Pacific Health 2020 and Genomics without Borders: Co-Production of Knowledge by Science and Society Partnership for Global Personalized Medicine.《2020年亚太地区健康与无国界基因组学：科学与社会伙伴关系促进全球个性化医疗的知识共同生产》
Curr Pharmacogenomics Person Med. 2011 Mar 1;9(1):1-5. doi: 10.2174/187569211794728841.
2
Bernard Lerer: recipient of the 2014 inaugural Werner Kalow Responsible Innovation Prize in Global Omics and Personalized Medicine (Pacific Rim Association for Clinical Pharmacogenetics).伯纳德·勒勒：2014年首届全球组学与个性化医学沃纳·卡洛负责任创新奖获得者（环太平洋临床药物遗传学协会）
OMICS. 2014 Apr;18(4):211-21. doi: 10.1089/omi.2014.0029. Epub 2014 Mar 20.
3
Advances in translational bioinformatics and population genomics in the Asia-Pacific.亚太地区转化生物信息学和群体基因组学的进展。
BMC Genomics. 2012;13 Suppl 7(Suppl 7):S1. doi: 10.1186/1471-2164-13-S7-S1. Epub 2012 Dec 13.
4
Genomic Medicine Without Borders: Which Strategies Should Developing Countries Employ to Invest in Precision Medicine? A New "Fast-Second Winner" Strategy.无国界基因组医学：发展中国家应采用哪些策略投资精准医学？一种新的“快速第二赢家”策略。
OMICS. 2017 Nov;21(11):647-657. doi: 10.1089/omi.2017.0141.
5
Equity should know no borders: The role of Australasian radiation oncologists in supporting radiation oncology services in low- and middle-income countries in the Asia-Pacific.公平不应有国界：澳大利亚和新西兰放射肿瘤学家在支持亚太地区低收入和中等收入国家放射肿瘤服务方面的作用。
J Med Imaging Radiat Oncol. 2021 Jul;65(4):410-417. doi: 10.1111/1754-9485.13191. Epub 2021 May 10.
6
Drug production, trafficking and trade in Asia and Pacific Island countries.亚太岛国的毒品生产、贩运和贸易。
Drug Alcohol Rev. 2006 Nov;25(6):647-50. doi: 10.1080/09595230600972850.
7
Promoting synergistic research and education in genomics and bioinformatics.促进基因组学和生物信息学领域的协同研究与教育。
BMC Genomics. 2008;9 Suppl 1(Suppl 1):I1. doi: 10.1186/1471-2164-9-S1-I1.
8
Personalized Medicine Across Disciplines and without Borders. Vural Özdemir speaks to Hannah Wilson, Commissioning Editor.跨学科与无国界的个性化医疗。武拉尔·厄兹德米尔与委托编辑汉娜·威尔逊对话。
Per Med. 2014;11(7):687-691. doi: 10.2217/pme.14.70.
9
Towards big data science in the decade ahead from ten years of InCoB and the 1st ISCB-Asia Joint Conference.展望未来十年的大数据科学：来自 InCoB 十年和第一届 ISCB-Asia 联合会议。
BMC Bioinformatics. 2011;12 Suppl 13(Suppl 13):S1. doi: 10.1186/1471-2105-12-S13-S1. Epub 2011 Nov 30.
10
The Asia Pacific Academic Consortium for Global Public Health and medicine: stabilizing south-south academic collaboration.亚太全球公共卫生与医学学术联合会：稳定南南学术合作。
Infect Dis Clin North Am. 2011 Sep;25(3):537-54, viii. doi: 10.1016/j.idc.2011.05.005.
引用本文的文献
1
Co-Design as Enabling Factor for Patient-Centred Healthcare: A Bibliometric Literature Review.协同设计作为以患者为中心的医疗保健的推动因素：文献计量学文献综述
Clinicoecon Outcomes Res. 2023 May 17;15:333-347. doi: 10.2147/CEOR.S403243. eCollection 2023.
2
Genomic translational research: Paving the way to individualized cardiac functional analyses and personalized cardiology.基因组转化研究：为个性化心脏功能分析和个性化心脏病学铺平道路。
Int J Cardiol. 2017 Mar 1;230:384-401. doi: 10.1016/j.ijcard.2016.12.097. Epub 2016 Dec 21.
3
All the post-genomic world is a stage: the actors and narrators required for translating pharmacogenomics into public health.整个后基因组时代就像一个舞台：将药物基因组学转化为公共卫生所需的参与者和讲述者。
Per Med. 2013 May 1;10(3):213-216. doi: 10.2217/pme.13.10.
4
Personalizing health care: feasibility and future implications.个性化医疗保健：可行性及未来影响。
BMC Med. 2013 Aug 13;11:179. doi: 10.1186/1741-7015-11-179.
5
Pharmacogenomics in Primary Care: A Crucial Entry Point for Global Personalized Medicine?基层医疗中的药物基因组学：全球个性化医疗的关键切入点？
Curr Pharmacogenomics Person Med. 2012;10(2):101-105. doi: 10.2174/187569212800626430.
6
End of the Beginning and Public Health Pharmacogenomics: Knowledge in 'Mode 2' and P5 Medicine.开端的结束与公共卫生药物基因组学：“模式2”和精准预防、预测、个体化、参与式、预防性（P5）医学中的知识
Curr Pharmacogenomics Person Med. 2012 Jan 1;10(1):1-6. doi: 10.2174/1875692111201010001.
7
Towards an Ecology of Collective Innovation: Human Variome Project (HVP), Rare Disease Consortium for Autosomal Loci (RaDiCAL) and Data-Enabled Life Sciences Alliance (DELSA).迈向集体创新生态学：人类变异组计划（HVP）、常染色体位点罕见病联盟（RaDiCAL）和数据驱动生命科学联盟（DELSA）。
Curr Pharmacogenomics Person Med. 2011 Dec 1;9(4):243-251. doi: 10.2174/187569211798377153.
8
Forward Look: Tenth Anniversary of the Human Genome Sequence and 21 Century Postgenomics Global Health - A Close Up on Africa and Women's Health.前瞻性展望：人类基因组序列十周年与21世纪后基因组时代的全球健康——聚焦非洲与女性健康
Curr Pharmacogenomics Person Med. 2011 Sep 1;9(3):148-155. doi: 10.2174/187569211796957511.
9
Personalized Medicine in the Age of Pharmacoproteomics: A Close up on India and Need for Social Science Engagement for Responsible Innovation in Post-Proteomic Biology.药物蛋白质组学时代的个性化医疗：聚焦印度以及后蛋白质组生物学中负责任创新的社会科学参与需求
Curr Pharmacogenomics Person Med. 2011 Mar 1;9(1):67-75. doi: 10.2174/187569211794728850.
本文引用的文献
1
Nutriproteomics and Proteogenomics: Cultivating Two Novel Hybrid Fields of Personalized Medicine with Added Societal Value.营养蛋白质组学和蛋白质基因组学：培育两个具有附加社会价值的个性化医学新型交叉领域。
Curr Pharmacogenomics Person Med. 2010 Dec 1;8(4):240-244. doi: 10.2174/187569210793368230.
2
Ethnogeographical structure of hepatitis B virus genotype distribution in Indonesia and discovery of a new subgenotype, B9.印度尼西亚乙型肝炎病毒基因型分布的种族地理学结构和新亚型 B9 的发现。
Arch Virol. 2011 May;156(5):855-68. doi: 10.1007/s00705-011-0926-y. Epub 2011 Feb 12.
3
Nutrigenomics in human intervention studies: current status, lessons learned and future perspectives.营养基因组学在人体干预研究中的应用：现状、经验教训和未来展望。
Mol Nutr Food Res. 2011 Mar;55(3):341-58. doi: 10.1002/mnfr.201000512. Epub 2011 Jan 31.
4
Health biotechnology innovation on a global stage.全球舞台上的健康生物技术创新。
Nat Rev Microbiol. 2011 Feb;9(2):137-43. doi: 10.1038/nrmicro2492.
5
Germs, genomics and global public health: How can advances in genomic sciences be integrated into public health in the developing world to deal with infectious diseases?微生物、基因组学与全球公共卫生：基因组科学的进展如何融入发展中世界的公共卫生领域以应对传染病？
Hugo J. 2009 Dec;3(1-4):5-9. doi: 10.1007/s11568-009-9131-4. Epub 2009 Nov 5.
6
Responsible innovation: a pilot study with the U.K. Engineering and Physical Sciences Research Council.负责任的创新：英国工程和物理科学研究理事会的试点研究。
Risk Anal. 2010 Nov;30(11):1699-707. doi: 10.1111/j.1539-6924.2010.01517.x.
7
The new age of global health governance holds promise.
Nat Med. 2010 Nov;16(11):1181. doi: 10.1038/nm1110-1181.
8
Research funding. Sustaining the data and bioresource commons.研究资金。维持数据和生物资源共享。
Science. 2010 Oct 29;330(6004):592-3. doi: 10.1126/science.1191506.
9
Meeting report: fourth Asia-Pacific nutrigenomics conference: gene-diet interactions in gut health, Auckland, New Zealand, February 21-25, 2010.
Biotechnol J. 2010 Sep;5(9):913-8. doi: 10.1002/biot.201000074.
10
Quality, quantity and harmony: the DataSHaPER approach to integrating data across bioclinical studies.质量、数量和协调：DataSHaPER 方法在生物临床研究中整合数据。
Int J Epidemiol. 2010 Oct;39(5):1383-93. doi: 10.1093/ije/dyq139. Epub 2010 Sep 2.
Zotero 插件